Literature DB >> 11004236

Inv(11)(p13p15) and myf-3(MyoD1) in a malignant extrarenal rhabdoid tumor of a premature newborn.

F Staehelin1, H Bissig, I Hösli, D R Betts, B W Schäfer, F A Scholl, W Holzgreve, T Kühne.   

Abstract

We present a premature newborn of 32 wk of gestation with a congenital malignant extrarenal rhabdoid tumor (MERT) on the right shoulder with generalized metastases. Standard histologic, immunohistochemical, molecular and cytogenetic methods were used in the evaluation of diagnostic material. Biopsy of a skin lesion showed the histologic features of a malignant rhabdoid tumor. Cytogenetic analysis of the tumor cells revealed an inv(11)(p13p15) and additionally, an increased expression of myf-3 (myogenic determination factor, MyoD1) and PAX3 was detected. These results suggest an origin of the neoplasm derived from a pluripotent cell with the potential of myogenic differentiation. Tumor suppressor genes located on chromosome 11p13 and 11p15 may play an important role for malignant rhabdoid tumor development and progression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11004236     DOI: 10.1203/00006450-200010000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  2 in total

1.  Surgery and actinomycin improve survival in malignant rhabdoid tumor.

Authors:  Ryan Horazdovsky; J Carlos Manivel; Edward Y Cheng
Journal:  Sarcoma       Date:  2013-02-03

2.  Ultrasound Presentation of a Disseminated Fetal and Neonatal Rhabdoid Tumor.

Authors:  Yolaine Joueidi; Aline Rousselin; Céline Rozel; Philippe Loget; Dominique Ranchere Vince; Sylvie Odent; Franck Bourdeaut; Vincent Lavoue; Maela Le Lous
Journal:  Case Rep Obstet Gynecol       Date:  2018-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.